Skip to main content
John Adams, DO, Oncology, Arlington, TX

JohnAdamsDOFACOI

Oncology Arlington, TX

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology

Physican/ Partner Texas Oncology

Dr. Adams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Adams' full profile

Already have an account?

  • Office

    906 W Randol Mill Rd
    # Arlingto
    Arlington, TX 76012
    Phone+1 817-261-0929
    Fax+1 817-543-4658

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
  • HCA Florida Healthcare/USF Morsani College of Medicine GME Largo Hospital
    HCA Florida Healthcare/USF Morsani College of Medicine GME Largo HospitalResidency, Internal Medicine, 1975 - 1978
  • A. T. Still University Kirksville College of Osteopathic Medicine
    A. T. Still University Kirksville College of Osteopathic MedicineClass of 1975
  • University of Texas at Austin Dell Medical School
    University of Texas at Austin Dell Medical SchoolB.S., Pharmacy, 1964 - 1969

Certifications & Licensure

  • TX State Medical License
    TX State License 1978 - 2025
  • AOA Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Outstanding Educator Sun Coast Hospital, 1981
  • Scholarship Texas Osteopathic Medical Association, 1971
  • Psi Sigma Alpha - National Osteopathic Scholastic Society
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting  
    Dicke KA, Hood DL, Arneson M, Fulbright L, DiStefano A, Firstenberg B, Adams J, Blumenschein GR, Exp Hematol, 1/1/1997
  • CAVe/XRT/McCFUD as an alternative to high dose chemotherapy and autologous bone marrow support for patients with advanced primary breast cancer  
    Blumenschein G, Jampolis S, DiStefano A, Firstenberg B, Adams J, Caderao J, Speer J, Hanks S, Proc Am Soc Clin Oncol, 1/1/1993
  • Concomitant continuous infusion radiosensitizing chemotherapy and radiation therapy in the treatment of stage 3 non small cell lung cancer  
    Speer J, Adams J, Blumenschein G, Caderao J, DiStefano A, Firstenberg B, Jampolis S, Hanks S, Proc Am Soc Clin Oncol, 1/1/1993

Books/Book Chapters

Abstracts/Posters

  • An aggressive approach to metastatic breast cancer is warranted
    Dicke KA, Blumenschein GR, DiStefano A, Firstenberg B, Adams JW, Arneson MA, Hanks S, Vaughan M, Schweichler LH, Ninth International Symposium on Autologous Blood and Marrow Transplantation; 17th International Cancer Congress (UICC); Current Issues in Cancer Management, Dallas, TX, 1998; Rio de Janeiro, Brazil, 1998, 1/1/1998
  • An aggressive approach to metastatic breast cancer is warranted
    Dicke KA, Blumenschein GR, DiStefano A, Firstenberg B, Adams JW, Arneson MA, Hanks S, Vaughan M, Schweichler LH, 32nd ASCO Annual Meeting; Proceedings of ASCO, Philadelphia, PA, 1/1/1996

Lectures

  • CAVe/XRT/McCFUD as an alternative to high dose chemotherapy (HDC) and autologous bone marrow support (ABMS) for patients with advanced primary breast cancer 
    San Antonio, TX - 1/1/1992
  • Combined modality treatment of advanced primary breast cancer 
    San Antonio, TX - 1/1/1991
  • Vibrio vulnificus infections: Who, Why, Where, and what to do 
    1/1/1989
  • Join now to see all

Professional Memberships